Ann Calby Miller
Director · INOVIO PHARMACEUTICALS, INC.
Individual
- 2025
- May 21, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Ann Calby Miller's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.95M in SMMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ann Calby Miller?
Ann Calby Miller is a corporate insider, tracked as Director of INOVIO PHARMACEUTICALS, INC. (INO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Ann Calby Miller last file a Form 4?
The most recent primary Form 4 on record is dated 21 May 2026, one of 2 filings going back to 2025.
